Ian T. Clark, Director at Guardant Health, Inc. (GH), sold 538 shares at $77.50 ($42K) on 2020-04-27, disclosed to the SEC on 2020-04-29.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| OLMA | SELL | 2025-12-23 | $15.7M | — | Filing → |
| GH | SELL | 2025-12-08 | $5.8M | — | Filing → |
| GH | SELL | 2025-06-20 | $646K | — | Filing → |